You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 13, 2024

VANOS Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Vanos patents expire, and what generic alternatives are available?

Vanos is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in VANOS is fluocinonide. There are nine drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the fluocinonide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Vanos

A generic version of VANOS was approved as fluocinonide by TARO on June 10th, 1987.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VANOS?
  • What are the global sales for VANOS?
  • What is Average Wholesale Price for VANOS?
Drug patent expirations by year for VANOS
Drug Prices for VANOS

See drug prices for VANOS

Drug Sales Revenue Trends for VANOS

See drug sales revenues for VANOS

Pharmacology for VANOS
Paragraph IV (Patent) Challenges for VANOS
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
VANOS Cream fluocinonide 0.1% 021758 1 2008-01-31

US Patents and Regulatory Information for VANOS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch VANOS fluocinonide CREAM;TOPICAL 021758-001 Feb 11, 2005 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for VANOS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch VANOS fluocinonide CREAM;TOPICAL 021758-001 Feb 11, 2005 ⤷  Sign Up ⤷  Sign Up
Bausch VANOS fluocinonide CREAM;TOPICAL 021758-001 Feb 11, 2005 ⤷  Sign Up ⤷  Sign Up
Bausch VANOS fluocinonide CREAM;TOPICAL 021758-001 Feb 11, 2005 ⤷  Sign Up ⤷  Sign Up
Bausch VANOS fluocinonide CREAM;TOPICAL 021758-001 Feb 11, 2005 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for VANOS

See the table below for patents covering VANOS around the world.

Country Patent Number Title Estimated Expiration
China 1617730 ⤷  Sign Up
Brazil 0215254 ⤷  Sign Up
Japan 2005524614 ⤷  Sign Up
Mexico PA04006014 COMPOSICIONES Y METODOS PARA INCREMENTAR EL SUMINISTRO DE CORTICOSTEROIDE. (COMPOSITIONS AND METHODS FOR ENHANCING CORTICOSTERIOD DELIVERY.) ⤷  Sign Up
Canada 2471041 COMPOSITIONS ET PROCEDES FAVORISANT L'ADMINISTRATION DE CORTICOSTEROIDES (COMPOSITIONS AND METHODS FOR ENHANCING CORTICOSTERIOD DELIVERY) ⤷  Sign Up
World Intellectual Property Organization (WIPO) 03055445 ⤷  Sign Up
European Patent Office 2363150 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.